However studies are not consistent, as other reports show considerable levels of S100A2 mRNA and/or protein in non-small cell lung cancer [19], esophageal squamous cell carcinoma and Barrett's adenocarcinoma [20, 21], and gastric cancer [22]. Here, S100A2 is linked to non-small cell lung carcinoma.